SCOPUS 정보 검색 플랫폼

Journal of the National Cancer Institute

Volumn 93, Issue 8, 2001, Pages 597-604

Methods to improve efficacy of intravesical mitomycin C: Results of a randomized phase III trial

(11) Au, Jessie L S a Badalament, Robert A a Wientjes, M Guillaume a Young, Donn C a Warner, Jill A a Venema, Pieter L b Pollifrone, David L a Harbrecht, Jeffrey D c Chin, Joseph L d Lerner, Seth P e Miles, Brian J e

a OHIO STATE UNIVERSITY (United States)

b LEYENBURG HOSPITAL (Netherlands)

c RIVERSIDE METHODIST HOSPITAL (United States)

d UNIVERSITY OF WESTERN ONTARIO (Canada)

e BAYLOR COLLEGE OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BICARBONATE; DOXORUBICIN; IMMUNOGLOBULIN; MITOMYCIN C; RECOMBINANT ALPHA2B INTERFERON; THIOTEPA;

ADULT; AGED; ALKALINIZATION; ANAMNESIS; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DEMOGRAPHY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; DYSURIA; EMPIRICISM; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; STANDARD; STATISTICAL ANALYSIS; STATISTICS; TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINE; URINE PH; URINE VOLUME;

EID: 0035906233 PISSN: 00278874 EISSN: None Source Type: Journal
DOI: 10.1093/jnci/93.8.597 Document Type: Article

Times cited : (252)

References (31)

1
- 85037409198
- Report on the management of non-muscle-invasive bladder cancer, stages Ta, T1 and Tis. Baltimore (MD): American Urological Association, Inc.
- (1999) , pp. 9-49
- Smith, J.A.¹ Labasky, R.F.² Montie, J.E.³ Rowland, R.G.⁴ Cockett, A.T.⁵ Fracchia, J.A.⁶

2
- 0025874949
- Method to study drug concentration-depth profiles in tissues: Mitomycin C in dog bladder wall
- (1991) Pharm Res , vol.8 , pp. 168-173
- Wientjes, M.G.¹ Dalton, J.T.² Badalament, R.A.³ Dasani, B.M.⁴ Drago, J.R.⁵ Au, J.L.⁶

3
- 0026406072
- Pharmacodynamics of mitomycin C in cultured human bladder tumors
- (1991) Cancer Res , vol.51 , pp. 3849-3856
- Schmittgen, T.D.¹ Wientjes, M.G.² Badalament, R.A.³ Au, J.L.⁴

4
- 0026000020
- Bladder wall penetration of intravesical mitomycin C in dogs
- (1991) Cancer Res , vol.51 , pp. 4347-4354
- Wientjes, M.G.¹ Dalton, J.T.² Badalament, R.A.³ Drago, J.R.⁴ Au, J.L.⁵

5
- 0026040188
- Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients
- (1991) Cancer Res , vol.51 , pp. 5144-5152
- Dalton, J.T.¹ Wientjes, M.G.² Badalament, R.A.³ Drago, J.R.⁴ Au, J.L.⁵

6
- 0027301129
- Penetration of mitomycin C in human bladder
- (1993) Cancer Res , vol.53 , pp. 3314-3320
- Wientjes, M.G.¹ Badalament, R.A.² Wang, R.C.³ Hassan, F.⁴ Au, J.L.⁵

7
- 0028223496
- Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients
- (1994) J Urol , vol.152 , Issue.2 PART 1 , pp. 374-378
- Chai, M.¹ Wientjes, M.G.² Badalament, R.A.³ Burgers, J.K.⁴ Au, J.L.⁵

8
- 0029877376
- Penetration of intravesical doxorubicin in human bladders
- (1996) Cancer Chemother Pharmacol , vol.37 , pp. 539-546
- Wientjes, M.G.¹ Badalament, R.A.² Au, J.L.³

9
- 0027200180
- Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer
- (1993) Cancer Chemother Pharmacol , vol.32 , pp. 255-262
- Wientjes, M.G.¹ Badalament, R.A.² Au, J.L.³

10
- 0005066507
- editors. Bladder. Manual for staging of cancer. Philadelphia (PA): Lippincott
- (1983)
- Beahrs, O.H.¹ Myers, M.H.²

11
- 0003295822
- Tumors of the urinary bladder
- Firminger HI, editor. Atlas of tumor pathology. 2nd series. Washington (DC): Armed Forces Institute of Pathology
- (1975) , pp. 6-17
- Koss, L.G.¹

12
- 0018687930
- A multiple testing procedure for clinical trials
- (1979) Biometrics , vol.35 , pp. 549-556
- O'Brien, P.C.¹ Fleming, T.R.²

13
- 0026650912
- Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times
- (1992) Int J Cancer , vol.51 , pp. 359-364
- De Bruijn, E.A.¹ Sleeboom, H.P.² van Helsdingen, P.J.³ van Oosterom, A.T.⁴ Tjaden, U.R.⁵ Maes, R.A.⁶

14
- 0003132410
- Cancer of the bladder
- DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 4th ed. Philadelphia (PA): Lippincott
- (1993) , pp. 1052-1072
- Fair, W.R.¹ Fuks, Z.Y.² Scher, H.I.³

15
- 58149363358
- Randomized intergroup comparison of bacillus Calmette-Guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder
- (1995) Urol Oncol , vol.1 , pp. 119-126
- Lamm, D.L.¹ Blumenstein, B.A.² Crawford, E.D.³ Crissman, J.D.⁴ Lowe, B.A.⁵ Smith, J.A.⁶

16
- 0019835111
- Reductive mechanism and alkylating activity of mitomycin C induced by rat liver microsomes
- (1981) Biochemistry , vol.20 , pp. 5056-5061
- Tomasz, M.¹ Lipman, R.²

17
- 0026669225
- Bioreductive activation of mitomycin C by DT-diaphorase
- (1992) Biochemistry , vol.31 , pp. 7879-7885
- Siegel, D.¹ Beall, H.² Senekowitsch, C.³ Kasai, M.⁴ Arai, H.⁵ Gibson, N.W.⁶

18
- 0029929226
- DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines
- (1996) Cancer Res , vol.56 , pp. 2823-2826
- Mikami, K.¹ Naito, M.² Tomida, A.³ Yamada, M.⁴ Sirakusa, T.⁵ Tsuruo, T.⁶

19
- 0029960764
- Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line
- (1996) Int J Cancer , vol.65 , pp. 852-857
- Singh, S.V.¹ Scalamogna, D.² Xia, H.³ O'Toole, S.⁴ Roy, D.⁵ Emerson, E.O.⁶

20
- 0026700546
- Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C
- (1992) Cancer Res , vol.52 , pp. 4752-4757
- Malkinson, A.M.¹ Siegel, D.² Forrest, G.L.³ Gazdar, A.F.⁴ Oie, H.K.⁵ Chan, D.C.⁶

21
- 0032190499
- Current issues in the enzymology of mitomycin C metabolic activation
- (1998) Gen Pharmacol , vol.31 , pp. 539-544
- Spanswick, V.J.¹ Cummings, J.² Smyth, J.F.³

22
- 0031021280
- Characterization of a polymorphism in NAD(P)H: Quinone xidoreductase (DT-diaphorase)
- (1997) Br J Cancer , vol.75 , pp. 69-75
- Traver, R.D.¹ Siegel, D.² Beall, H.D.³ Phillips, R.M.⁴ Gibson, N.W.⁵ Franklin, W.A.⁶

23
- 0026505943
- NAD(P)H: Quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
- (1992) Cancer Res , vol.52 , pp. 797-802
- Traver, R.D.¹ Horikoshi, T.² Danenberg, K.D.³ Stadlbauer, T.H.⁴ Danenberg, P.V.⁵ Ross, D.⁶

24
- 0025352024
- Decreased NADPH: Cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin under aerobic but not hypoxic conditions
- (1990) Cancer Res , vol.50 , pp. 4692-4697
- Hoban, P.R.¹ Walton, M.I.² Robson, C.N.³ Godden, J.⁴ Stratford, I.J.⁵ Workman, P.⁶

25
- 0025673868
- Activation of mitomycin C by NADPH: Cytochrome P-450 reductase
- (1990) Cancer Res , vol.50 , pp. 7789-7792
- Bligh, H.F.¹ Bartoszek, A.² Robson, C.N.³ Hickson, I.D.⁴ Kasper, C.B.⁵ Beggs, J.D.⁶

26
- 0002669294
- Immunotherapy (BCG) versus chemotherapy (MMC) in intravesical treatment of superficial bladder cancer
- deKernion JB, editor. International Society of Urology Reports. Immunotherapy of urological tumors. New York (NY): Churchill-Livingstone
- (1990) , pp. 13-26
- Jauhiainen, K.¹ Rintala, E.² Alfthan, O.³

27
- 0030213699
- A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma
- (1996) J Urol , vol.156 , Issue.2 PART 1 , pp. 372-376
- Lundholm, C.¹ Norlen, B.J.² Ekman, P.³ Jahnson, S.⁴ Lagerkvist, M.⁵ Lindeborg, T.⁶ Olsson, J.L.⁷

28
- 0023831066
- BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial
- (1988) Urology , vol.31 , Issue.SUPPL. 3 , pp. 20-25
- DeBruyne, F.M.¹ van der Meijden, A.P.² Geboers, A.D.³ Franssen, M.P.⁴ van Leeuwen, M.J.⁵ Steerenberg, P.A.⁶

29
- 0002058825
- Prospective randomized study of adjuvant therapy after complete resection of superficial bladder cancer: Mitomycin C vs BCG Connaught vs BCG TUR alone
- deKernion JB, editor. International Society of Urology Reports. Immunotherapy of urological tumors. New York (NY): Churchill-Livingstone
- (1990) , pp. 27
- Ruebben, H.¹ Graf-Dubberstein, C.² Ostwald, R.³ Staufferberg, A.⁴ Jaeger, N.⁵ Deutz, F.J.⁶

30
- 9444281414
- A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: Transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating clinics
- (1996) J Urol , vol.156 , pp. 962-966
- Krege, S.¹ Giani, G.² Meyer, R.³ Otto, T.⁴ Rubben, H.⁵

31
- 0032169530
- Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guerin-RIVM and mitomycin C in superficial bladder cancer
- EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group
- (1998) Urology , vol.52 , pp. 403-410
- Witjes, J.A.¹ van der Meijden, A.P.² Sylvester, L.C.³ Debruyne, F.M.⁴ van Aubel, A.⁵ Witjes, W.P.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.